JMJelena Marjanovic

Jelena Marjanovic

*This is an algorithmically generated author record based on publicly available information.

Jelena Marjanovic has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Marjana Tomic-Canic

    Wound Healing and Regenerative Medicine Research Program, Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA

    5 shared publications
  • Irena Pastar

    Wound Healing and Regenerative Medicine Research Program, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami Florida USA

    4 shared publications
  • Jamie L. Burgess

    Wound Healing and Regenerative Medicine Research Program, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA

    3 shared publications
  • Seth Ray Thaller

    DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL

    3 shared publications
  • Beatriz Abdo Abujamra

    Wound Healing and Regenerative Medicine Research Program, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA

    2 shared publications
  • Dušan Radojević

    Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia

    2 shared publications

Latest Publications

  • PTEN acts as a master mediator of nonhealing venous leg ulcers by suppressing immune response, angiogenesis, and lymphangiogenesis.

    by Jelena Marjanovic, Beatriz Abdo Abujamra, Natasa Strbo, Laura I Padula, Anthony J Griswold, Ivan Jozic, Raji R Nagalla, Jamie L Burgess, Sandra Predic, Rivka C Stone, et al.

    Venous leg ulcers (VLUs) are the most common cause of leg ulcers, yet only 44% heal with standard-of-care treatment, highlighting the critical need for better understanding of their cellular pathology. We used both bulk and single-cell RNA sequencing (scRNA-seq) to identify molecular mechanisms and cellular functions contributing to VLU pathophysiology. scRNA-seq of chronic VLUs revealed impairments in immune, lymph endothelial, and endothelial cells, along with underlying signaling pathways. Next, bulk RNA-seq was performed alongside weekly wound assessments over 4 weeks in patients with VLUs receiving standard care, classifying them as healers or nonhealers on the basis of ≥50% closure. Transcriptomes of healing and nonhealing VLUs were compared with those of human acute wounds, revealing marked suppression of inflammatory response, lymphangiogenesis, and angiogenesis in nonhealing VLUs. In contrast, healing VLUs resembled the gene expression signature of physiological, acute wound healing. Reduced inflammatory response underlined the nonhealing VLU signature, associated with impaired leukocyte transmigration and egress, with suppression of the activity of multiple kinases. Bioinformatic analyses pinpointed PTEN (phosphatase and TENsin homolog) as a master regulator of these processes and signaling pathways. Increased PTEN protein expression was confirmed in nonhealing compared with healing VLUs. Furthermore, pharmacological PTEN inhibition enhanced immune response and pro-inflammatory signals, angiogenesis, and lymphangiogenesis, which resulted in accelerated acute wound closure in mice. These findings support PTEN as a key regulator of the nonhealing VLU phenotype controlling multiple processes responsible for impaired wound healing and highlight its potential use as a therapeutic target to promote wound closure in VLUs.


  • Open Access

    NDR1/2 kinases regulate cell polarization and cell motility through Cdc42 GTPase and Pard3 signaling in mammalian cells

    by Jun Gu, Jelena Marjanovic, Marjana Tomic-Canic, Fangliang Zhang, Fulvia Verde

    Controlling cell polarity and the directionality of cell motility is critical for effective cell migration during wound healing. NDR (nuclear dbf2-related) kinase pathways have roles in cell morphogenesis that are conserved from yeast to humans. Here, we reveal that knockdown of NDR1/2 kinases significantly alters cell size, shape, and the actin cytoskeleton, while reducing migration persistence and impairing cell polarization in wound healing assays. Mechanistically, we find that NDR1/2 kinases regulate the spatial and temporal dynamics of Cdc42 GTPase. Reduced NDR kinase levels increase Cdc42 GTPase activity and disrupt Pard3 subcellular location. NDR kinases phosphorylate Pard3 at Serine144, and overexpressing Pard3 can partially restore wound healing in NDR-depleted cells, an effect lost when Serine144 is mutated. Finally, we determine that NDR1 knockdown significantly impairs wound closure in human skin ex vivo wound healing assays, highlighting NDR kinase physiological importance. Collectively, this study demonstrates that NDR kinases modulate cell motility and polarization through the control of Pard3 and Cdc42 signaling in human fibroblasts.

  • Cover Image

    by Miroslav Dinić, Jamie L. Burgess, Jovanka Lukić, Paola Catanuto, Dušan Radojević, Jelena Marjanović, Rebecca Verpile, Seth R. Thaller, Tammy Gonzalez, Nataša Golić, et al.

  • Open Access

    Postbiotic lactobacilli induce cutaneous antimicrobial response and restore the barrier to inhibit the intracellular invasion of Staphylococcus aureus in vitro and ex vivo

    by Miroslav Dinić, Jamie L. Burgess, Jovanka Lukić, Paola Catanuto, Dušan Radojević, Jelena Marjanović, Rebecca Verpile, Seth R. Thaller, Tammy Gonzalez, Nataša Golić, et al.

    Intracellular pathogens including Staphylococcus aureus contribute to the non‐healing phenotype of chronic wounds. Lactobacilli, well known as beneficial bacteria, are also reported to modulate the immune system, yet their role in cutaneous immunity remains largely unknown. We explored the therapeutic potential of bacteria‐free postbiotics, bioactive lysates of lactobacilli, to reduce intracellular S. aureus colonization and promote healing. Fourteen postbiotics derived from various lactobacilli species were screened, and Latilactobacillus curvatus BGMK2‐41 was selected for further analysis based on the most efficient ability to reduce intracellular infection by S. aureus diabetic foot ulcer clinical isolate and S. aureus USA300. Treatment of both infected keratinocytes in vitro and infected human skin ex vivo with BGMK2‐41 postbiotic cleared S. aureus . Keratinocytes treated in vitro with BGMK2‐41 upregulated expression of antimicrobial response genes, of which DEFB4 , ANG , and RNASE7 were also found upregulated in treated ex vivo human skin together with CAMP exclusively upregulated ex vivo. Furthermore, BGMK2‐41 postbiotic treatment has a multifaceted impact on the wound healing process. Treatment of keratinocytes stimulated cell migration and the expression of tight junction proteins, while in ex vivo human skin BGMK2‐41 increased expression of anti‐inflammatory cytokine IL‐10, promoted re‐epithelialization, and restored the epidermal barrier via upregulation of tight junction proteins. Together, this provides a potential therapeutic approach for persistent intracellular S. aureus infections.


  • Dichotomous role of miR193b-3p in diabetic foot ulcers maintains inhibition of healing and suppression of tumor formation

    by Jelena Marjanovic, Horacio A. Ramirez, Ivan Jozic, Rivka C. Stone, Tongyu C. Wikramanayake, Cheyanne R. Head, Beatriz Abdo Abujamra, Nkemcho Ojeh, Robert S. Kirsner, Hadar Lev-Tov, et al.

    Despite the hyperproliferative environment marked by activation of β-catenin and overexpression of c-myc , the epidermis surrounding chronic diabetic foot ulcers (DFUs) is clinically hypertrophic and nonmigratory yet does not undergo malignant transformation. We identified miR193b-3p as a master regulator that contributes to this unique cellular phenotype. We determined that induction of tumor suppressor miR193b-3p is a unique feature of DFUs that is not found in venous leg ulcers, acute wounds, or cutaneous squamous cell carcinoma (SCC). Genomic analyses of DFUs identified suppression of the miR193b-3p target gene network that orchestrates cell motility. Inhibition of migration and wound closure was further confirmed by overexpression of miR193b-3p in human organotypic and murine in vivo wound models, whereas miR193b-3p knockdown accelerated wound reepithelialization in human ex vivo and diabetic murine wounds in vivo. The dominant negative effect of miR193b-3p on keratinocyte migration was maintained in the presence of promigratory miR31-5p and miR15b-5p, which were also overexpressed in DFUs. miR193b-3p mediated antimigratory activity by disrupting stress fiber formation and by decreasing activity of GTPase RhoA. Conversely, miR193b-3p targets that typically participate in malignant transformation were found to be differentially regulated between DFUs and SCC, including the proto-oncogenes KRAS (Kirsten rat sarcoma viral proto-oncogene) and KIT (KIT proto-oncogene). Although miR193b-3p acts as a tumor suppressor contributing to low tumor incidence in DFUs, it also acts as a master inhibitor of cellular migration and epithelialization in DFUs. Thus, miR193b-3p may represent a target for wound healing induction, cancer therapeutics, and diagnostics.